PHARMACEUTICAL COMPOSITION HAVING VASOCONSTRICTING, ANTICONGESTANT AND ANTI-INFLAMMATORY ACTIVITY (EMBODIMENTS)

The invention relates to the field of the pharmaceutical industry and medicine and can be used for the production and application of pharmaceutical compositions having vasoconstricting, anticongestant and anti-inflammatory activity in cases of acute rhinitis, inflammatory processes of the maxillary...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LOBKO, VLADIMIR PAVLOVICH, CHELYAEVA, ANASTASIYA GENNADIEVNA
Format:	Patent
Sprache:	eng ; fre ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the field of the pharmaceutical industry and medicine and can be used for the production and application of pharmaceutical compositions having vasoconstricting, anticongestant and anti-inflammatory activity in cases of acute rhinitis, inflammatory processes of the maxillary sinuses, nosebleeds and conjunctivitis. The problem of the invention consists in producing a pharmaceutical composition on the basis of the preparation naphazoline by introducing mineral substances into the pharmaceutical composition, and substituting 12C carbon isotopes with 13C carbon isotopes in the pharmaceutical composition. L'invention concerne les domaines de l'industrie pharmaceutique et de la médecine et peut s'utiliser pour créer et appliquer des compositions pharmaceutiques possédant une activité vasocontrictive, anticongestive, anti-inflammatoire lors de rhinites aigues, de processus inflammatoires des antres maxillaires du nez, de saignements du nez et de conjonctivite. L'invention vise une préparation pharmaceutique à base de naphazoline grâce à l'inclusion dans la composition pharmaceutique de substances minérales, de remplacement dans la composition pharmaceutique des isotopes de carbone 12C pharmaceutique par des isotopes de carbone 13C.